Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2006-02-09 Capital/Financing Update
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes details about the completion of an acquisition, entry into a material definitive agreement, and financing arrangements including a loan agreement. It also references exhibits such as the stock purchase agreement, loan agreements, promissory notes, and guaranties. The document does not contain full financial statements or detailed financial performance data but rather announces significant corporate events and agreements. This fits the category of Capital/Financing Update (CAP) because it involves financing activities related to the acquisition and loan agreements. The document length (6518 characters) and content confirm it is not merely an announcement of a report but a substantive filing about financing and acquisition completion.
2006-02-09 English
Major Shareholding Notification 2006
Major Shareholding Notification
2006-02-07 English
Major Shareholding Notification 2006
Major Shareholding Notification
2006-01-31 English
Regulatory Filings 2006
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is used for current reports to announce major events that shareholders should know about. The content describes an amendment to a stock purchase agreement, extending the closing date for the purchase of stock of Chelated Minerals Corporation. This is a material definitive agreement update, which is typically reported in an 8-K. The document does not contain financial statements or detailed financial data, nor is it an earnings release or annual report. It is not a proxy, voting result, or management change announcement. The document is a regulatory filing reporting a material event, so it fits best under Regulatory Filings (RNS). The document length is short (2758 characters), and it is not announcing a report publication but reporting a material event. Therefore, the classification is RNS with high confidence.
2006-01-10 English
Director's Dealing 2006
Director's Dealing
2006-01-03 English
Director's Dealing 2006
Director's Dealing
2006-01-03 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.